Number of subjects, N |
65 |
68 |
Age, years (%) |
13.1 ± 2.6 |
12.8 ± 2.9 |
6-12 |
29 (45%) |
30 (44%) |
13-18 |
36 (55%) |
38 (56%) |
Range |
7.5-18.4 |
6.3-18.4 |
Gender, N (%) |
|
Female |
37 (57) |
39 (57) |
Male |
28 (43) |
29 (43) |
Diabetes duration, years |
6.3 ± 3.3 |
6.6 ± 3.1 |
Total daily insulin dose, U/kg/day |
0.93 ± 0.23 |
0.95 ± 0.24 |
Continuous glucose monitor (CGM) use, N (%) |
Current |
45 (69%) |
44 (65%) |
In past, but not current |
12 (18%) |
14 (21%) |
Never |
8 (12%) |
10 (15%) |
BMI percentile |
60 ± 25 |
67 ± 25 |
BMI z-score |
0.35 ± 0.86 |
0.58 ± 0.89 |
Ethnicity, N (%) |
|
White non-Hispanic |
60 (94%) |
53 (79%) |
Black non-Hispanic |
0 (0) |
2 (3%) |
Hispanic or Latino |
0 (0) |
4 (6%) |
Asian |
3 (5%) |
4 (6%) |
Native Hawaiian/Other Pacific Islander |
0 (0) |
1 (1%) |
More than one race |
1 (2%) |
3 (4%) |
Highest parent education level, N (%) |
High school diploma or less |
7 (11%) |
2 (3%) |
Associates degree or some College but no degree |
17 (28%) |
19 (30%) |
Bachelor’s degree |
18 (30%) |
13 (20%) |
Master’s degree |
8 (13%) |
15 (23%) |
Doctoral or professional degree |
11 (18%) |
15 (23%) |
Glycated hemoglobin at baseline, mmol/mol (%) |
66 ± 8 |
67 ± 8 |
|
[8.2 ± 0.7] |
[8.3 ± 0.8] |
Range (%) |
53-83 |
53-89 |
|
[7.0-9.7] |
[7.0-10.3] |
<64 mmol/mol (<8.0%), N (%) |
28 (43%) |
29 (43%) |
64 to <75 mmol/mol (8.0 to <9.0%), N (%) |
26 (40%) |
25 (37%) |
≥75 mmol/mol (≥9.0%), N (%) |
11 (17%) |
14 (21%) |